And the winner is…Amsterdam takes EMA HQ
November 21, 2017Manufacturing and Production, Medical Communications biotech, drugs, pharma, pharmaceutical
In a decision that was likened to a penalty shoot-out, Amsterdam was announced as the winner of the race to …
Partnerships hold the key to making HIV history
November 20, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HIV, Janssen, pharma
Brian Woodfall, Global Head of Late Development, Infectious Diseases at Janssen, explains why a future without HIV can only be …
Acorda scraps Parkinson’s drug after five trial deaths
November 20, 2017Research and Development, Sales and Marketing Acorda therapeutics, Parkinson's, patient deaths, pharma
Acorda Therapeutics has announced that it is terminate development of its Parkinson’s therapy tozadenant after five deaths were reported as …
Children are still prescribed codeine despite FDA warnings, study finds
November 20, 2017Medical Communications, Research and Development, Sales and Marketing US, codeine, opioid crisis, opioids, pharma
A new study from the American Academy of Pediatrics has found that, despite warnings from the FDA, doctors are still …
Roche unveils strong combination treatment data in lung cancer
November 20, 2017Research and Development, Sales and Marketing Cancer, NSCLC< lung cancer, Roche, avastin, immunotherapy, pharma, tecentriq
Roche has unveiled new Phase 3 efficacy data which showed strong findings for its immunotherapy Tecentriq (atezolizumab) in combination with …
Novartis’s Tasigna scores EU approval in paediatric patients
November 20, 2017Sales and Marketing Europe, Novartis, Tasigna, chronic myeloid leukaemia, pharma
Novartis’s Tasigna (nilotinib) has received European Commission approval for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in …
Samsung Bioepis’ Ontruzant becomes first Herceptin biosimilar approved in Europe
November 20, 2017Sales and Marketing EMA, Herceptin, Roche, Samsung Bioepis
Samsung Bioepis has announced that Ontruzant, the company’s biosimilar version of Roche’s Herceptin, has been awarded marketing authorisation in Europe …
UK austerity measures to social care led to 120,000 deaths
November 17, 2017Medical Communications UK, austerity, biotech, drugs, pharma, pharmaceutical, social care
A new study has claimed that austerity measures introduced since 2010 are linked to 120,000 deaths across England. The research …
Top Ten most popular articles on Pharmafile.com this week
November 17, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, pharmafile, top ten
It’s Friday, and it’s time for another rundown of our most popular articles with our readers this week. Besides a …
FDA expands use of Pfizer’s Sutent in kidney cancer
November 17, 2017Medical Communications, Sales and Marketing Cancer, Kidney cancer, Pfizer, Sutent, pharma
Pfizer has announced that the FDA has expanded the use of its tyrosine kinase inhibitor Sutent (sunitinib malate) to include …
Roche’s haemophillia A treatment gets nod but with black box warning
November 17, 2017Medical Communications, Sales and Marketing Hemlibra, Roche, biotech, drugs, pharma, pharmaceutical
Roche needs its pipeline to pick up quick successes, with its big earners are looking at precipitous patent cliffs, and, …
Boots under fire from Labour MPs over broken contraceptive promise
November 17, 2017Medical Communications, Sales and Marketing Boots, biotech, drugs, morning after pill, pharma, pharmaceutical
Boots, a UK high-street pharmacy, has come under pressure from Labour MPs after it failed to adhere to its own …
Trump nominates Ex-Lilly exec for health secretary role
November 16, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Alex Azar is officially President Trump’s nominee for the position as head of the Health and Human Services (HHS) agency, …
Stem cell therapy fails to improve symptoms of peripheral artery disease
November 16, 2017Research and Development Stem cells, peripheral artery disease, pharma, stem cell therapy, trial failure
A new study has revealed that a promising stem cell therapy failed to improve ability to walk in patients with …
FDA approves electronic nerve stimulator for opioid withdrawal
November 16, 2017Sales and Marketing NNS-2 Bridge, biotech, drugs, opioid, pharma, pharmaceutical
A device that delivers electronic pulses to the area around the ear, designed to stimulate the brain in order to …
GSK gets EU go-ahead for triple therapy inhaler in COPD
November 16, 2017Sales and Marketing COPD, FDA, GSK, Trelegy Ellipta, pharma
The EMA has awarded EU marketing authorisation to GlaxoSmithKline and Innovia’s single inhaler triple therapy Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for …
NICE approves Novartis and Pfizer’s rival breast cancer drugs
November 16, 2017Sales and Marketing Kisqali, Novartis, Pfizer, biotech, drugs, ibrance, pharma, pharmaceutical
NICE has announced that it has given the nod to two new treatments for breast cancer with the approval of …
Genentech cements relationship with Arvinas with $650m deal
November 16, 2017Research and Development, Sales and Marketing Arvinas, Genentech, Roche, biotech, drugs, pharma, pharmaceutical
Genentech first signed a deal with Arvinas, a biotech focused on drugs within the protein degradation class, back in 2015. …
Navigating the new Clinical Trial Regulation with DIA
November 16, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, dia, drugs, pharma, pharmaceutical
For those stakeholders involved with clinical trials in Europe, the new Clinical Trial Regulation to be introduced in 2019 will …
Pfizer promotes Albert Bourla to newly-created COO role
November 15, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
In a sizeable shake-up of its business operations, Pfizer has promoted Albert Bourla (pictured) to the role of Chief Operating …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
